Back to top

Roche’s Genentech launches DTC program amid Trump’s MFN directive

Roche’s Genentech launches DTC program amid Trump’s MFN directive

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Amazon.com, Inc. (AMZN)

AstraZeneca PLC (AZN)

Pfizer Inc. (PFE)

Roche Holding AG (RHHBY)

Shionogi & Co., Ltd. Unsponsored ADR (SGIOY)